ANIMALHEALTHX Weekly is your weekly pulse on the global animal health industry, delivering curated insights, executive interviews, regulatory updates, innovation breakthroughs, and market movements shaping the future of veterinary medicine and animal care.
Cover Story
• Boehringer & Eko Launch Canine AI Tool
AI-powered auscultation enabling early detection of heart murmurs in dogs.
Featured Article
• Caring for Cats: Elevating Feline Health
A deep dive into how nutrition and holistic care are redefining feline health and longevity.
Regulatory Response
• Elanco Secures Screwworm Emergency Use
Emergency authorizations strengthen U.S. livestock protection against parasitic threats.
Business Development Update
• Genflow Expands Canine SIRT6 Program
Rising industry interest in gene therapy for longevity and age-related diseases in dogs.
Boehringer, Eko Debut Canine AI Tool
Clinical Innovation
Boehringer Ingelheim, in partnership with Eko Health, has launched Eko Vet+ with CANINEBEAT AI, an AI‑powered digital auscultation solution that detects, visualizes, and grades heart murmurs in dogs to support earlier recognition of cardiac disease in general practice.
Key Highlights
- The Eko CORE digital attachment converts most standard single‑tube stethoscopes into digital devices, amplifying heart sounds by up to 40 times and applying advanced noise cancellation to help reveal subtle murmurs that might otherwise be missed.
- The CANINEBEAT AI algorithm is a canine‑specific murmur detection model trained and validated on more than 4,000 annotated heart sound recordings from over 3,400 dogs, delivering greater than 95% sensitivity and specificity for murmurs associated with structural heart disease, particularly myxomatous mitral valve disease.
- The Eko Vet+ app captures short recordings, streams real‑time phonocardiogram waveforms, and returns murmur presence and a supported grade within seconds, generating visual and shareable reports to enhance documentation and client communication.
Impact
Helps shift canine cardiology from reactive detection of advanced disease to earlier identification and intervention, improving diagnostic confidence, supporting more consistent murmur screening in primary care, and potentially enhancing long‑term outcomes as the solution rolls out across the U.S., U.K., Germany, and additional markets through 2026.
Caring for Cats: Smarter Feline Health
The landscape of companion animal care is rapidly evolving, with feline health gaining increased attention as cats become cherished members of modern households. Unlike traditional perceptions of cats as low-maintenance pets, today’s pet owners are embracing a more proactive and informed approach to feline care. At the center of this shift lies nutrition, now recognized as a foundational element in supporting longevity, vitality, and overall well-being in cats.
One of the most notable trends in feline care is the growing demand for specialized and premium nutrition. Cats have unique dietary requirements as obligate carnivores, necessitating protein-rich diets with essential nutrients such as taurine, arachidonic acid, and vitamin A. Pet owners are increasingly seeking tailored formulations that cater to specific life stages—from kittens to senior cats—as well as health conditions such as renal disease, urinary tract issues, and food sensitivities. This move toward personalized nutrition reflects a broader emphasis on precision care in the feline health space.
Functional nutrition is also reshaping how cats are fed. Modern diets now incorporate ingredients designed to deliver targeted health benefits. Omega-3 fatty acids support skin and coat health, probiotics aid digestive balance, and antioxidants contribute to immune resilience. Additionally, specialized formulations addressing hairball control, dental health, and weight management are becoming more prevalent, bridging the gap between everyday feeding and preventive healthcare.
Preventive care extends beyond nutrition, encompassing routine veterinary visits, vaccinations, parasite control, and behavioral enrichment. Indoor cats, in particular, benefit from environmental stimulation such as interactive toys, climbing structures, and mental engagement to prevent obesity and stress-related conditions. Early intervention through proper diet and lifestyle management plays a critical role in reducing the risk of chronic diseases and enhancing quality of life.
Innovation in feline care products is further transforming the ecosystem. Advances in pet food processing and ingredient sourcing are improving nutritional integrity and safety. The rise of wet, fresh, and minimally processed diets aligns with cats’ natural hydration needs and feeding behaviors. Smart technologies, including automated feeders and health-monitoring devices, are also enabling more precise and consistent care.
Sustainability is emerging as an important consideration in feline nutrition. Pet food manufacturers are exploring alternative protein sources and environmentally responsible practices to reduce their ecological footprint while maintaining nutritional adequacy. This aligns with the values of increasingly conscious pet owners who seek both quality and sustainability in their purchasing decisions.
In conclusion, feline care is undergoing a meaningful transformation, with nutrition and preventive health at its core. As awareness grows and innovation continues, the focus remains on delivering comprehensive care strategies that support healthier, happier, and longer lives for cats.
Regulatory Response
Elanco has received emergency US regulatory authorizations for Negasunt Powder and Tanidil for the prevention and treatment of New World screwworm infestations in livestock, bolstering national preparedness against a high‑impact parasitic threat.
Key Highlights
- Negasunt Powder has been granted Emergency Use Authorization, while Tanidil has been cleared under a Section 18 emergency exemption, following detections of New World screwworm near the US–Mexico border that elevate the risk of cross‑border spread.
- Distribution of both products will be coordinated through USDA APHIS and the National Veterinary Stockpile, providing veterinarians and producers with ready‑to‑deploy tools for rapid intervention under licensed veterinary supervision, defined treatment limits, and withdrawal periods.
- Use is restricted and subject to strict safety protocols, including PPE requirements and regulatory oversight, while producers are urged to pair treatment readiness with vigilant wound monitoring and robust fly and tick control programs to reduce infestation risk.
Impact
Supports a proactive, biosecurity‑driven approach to livestock health by enabling earlier response to a potentially devastating parasite, helping protect animal welfare, productivity, and the economic stability of US livestock systems.
Business Development Update
Genflow Biosciences Plc is expanding its engagement with leading global animal health companies, signing additional confidentiality agreements to support the structured evaluation of its canine SIRT6 gene therapy programme for age‑related diseases.
Key Highlights
- The widened set of Tier‑1 counterparties follows positive preliminary interim data from Genflow’s SLAB study in aged dogs, where its SIRT6 centenarian gene therapy (GF‑1002) demonstrated a favourable safety profile, superior survival versus controls, and functional improvements across quality of life, muscle mass maintenance, frailty scores, and overall condition.
- Multiple major animal health companies are now reviewing Genflow’s underlying technology and dataset under confidentiality, reflecting rising industry interest in longevity‑focused gene therapies for companion animals and the potential of SIRT6‑based approaches to address age‑related conditions.
- While discussions remain exploratory, the breadth of engagement positions Genflow early for potential future collaborations, including partnering or licensing scenarios, pending further data maturation and strategic fit.
Impact
Highlights growing traction for gene therapy and longevity science within the animal health industry, with Genflow prioritizing continued data generation and clinical advancement while Tier‑1 players actively assess its canine SIRT6 platform as a possible new modality beyond traditional therapeutics.
Advancing Animal Health Through Innovation & Care
This edition highlights key advancements shaping companion and livestock animal health. From evolving feline care driven by precision nutrition and preventive strategies to AI-enabled tools improving early detection of canine cardiac conditions, innovation is redefining clinical outcomes. Regulatory action strengthens preparedness against livestock parasites, while gene therapy gains traction as a future modality for age-related diseases in dogs. Together, these developments underscore a shift toward proactive, technology-driven, and science-backed approaches across the global animal health ecosystem.
The Pulse of Global Animal Health
Enjoyed this edition? Share it with colleagues, partners, and fellow leaders shaping the future of animal health.
The industry is evolving at remarkable speed—from breakthrough biotech partnerships and regulatory milestones to AI-driven diagnostics and next-generation veterinary innovations. Staying informed isn’t just valuable—it’s essential to staying ahead.
Forward this newsletter, repost it, and help foster a more connected, informed, and forward-thinking global animal health community.
